2m 2m 2m 2m 2m 2m 2m
HCA Healthcare (HCA)
NYSE
$387.00+$10.00 (+2.65%)
Price as of Jun 23, 2026 4:10 PM EDT- $83.6BMarket Cap
- 0.22%1-Year Change
- Medical Care FacilitiesIndustry
HCA Healthcare (HCA)
$387.00+$10.00 (+2.65%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 75.6B +7.08% | 70.6B +8.67% | 65.0B +7.86% | 60.2B +2.52% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 75.6B +7.08% | 70.6B +8.67% | 65.0B +7.86% | 60.2B +2.52% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 3.5B +6.37% | 3.3B +7.64% | 3.1B +3.64% | 3.0B +4.07% | |
Total Operating Expenses | 65.8B +5.94% | 62.1B +8.41% | 57.3B +10.86% | 51.7B +5.59% | |
Operating Profit | 9.8B +15.36% | 8.5B +10.60% | 7.7B -10.19% | 8.6B -12.74% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -2.2B +9.07% | -2.1B +6.35% | -1.9B +11.32% | -1.7B +11.17% | |
Interest Income and Expense and Net | -2.2B +9.07% | -2.1B +6.35% | -1.9B +11.32% | -1.7B +11.17% | |
Total Nonoperating Income and Expense | 2.2B +9.07% | 2.1B +6.35% | 1.9B +11.32% | 1.7B +11.17% | |
Income before Taxes | 9.8B +15.36% | 8.5B +10.60% | 7.7B -10.19% | 8.6B -12.74% | |
Income Taxes | 2.0B +9.86% | 1.9B +15.54% | 1.6B -7.50% | 1.7B -17.33% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 6.8B +17.78% | 5.8B +9.88% | 5.2B -7.11% | 5.6B -18.88% | |
Net Income from Continuing Operations Applicable to Common | 9.8B +15.36% | 8.5B +10.60% | 7.7B -10.19% | 8.6B -12.74% | |
Basic EPS and Net Income | 28.70 +28.87% | 22.27 +15.69% | 19.25 -0.93% | 19.43 -9.71% | |
Diluted EPS and Net Income | 28.33 +28.77% | 22.00 +15.97% | 18.97 -0.94% | 19.15 -9.50% | |
Basic Weighted Average Shares | 236.4M -8.58% | 258.6M -5.07% | 272.4M -6.18% | 290.3M -10.20% | |
Diluted Weighted Average Shares | 239.5M -8.52% | 261.8M -5.28% | 276.4M -6.19% | 294.7M -10.37% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.0B -46.20% | 1.9B +106.74% | 935.0M +2.97% | 908.0M -37.42% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.0B -46.20% | 1.9B +106.74% | 935.0M +2.97% | 908.0M -41.57% | |
Total Current Assets | 15.8B -3.84% | 16.4B +9.96% | 14.9B +9.41% | 13.6B +0.75% | |
Accumulated Depreciation | 35.1B +6.15% | 33.1B +7.35% | 30.8B +5.66% | 29.2B +6.94% | |
Property and Plant and Equipment and Net | 31.1B +5.87% | 29.4B +6.13% | 27.7B +8.37% | 25.6B +6.28% | |
Total Long-Term Assets | 255.0M +10.87% | 230.0M +25.00% | 184.0M -38.26% | 298.0M -50.17% | |
Total Assets | 60.7B +2.03% | 59.5B +5.87% | 56.2B +7.20% | 52.4B +3.34% | |
Income Taxes Payable | 504.0M +20.29% | 419.0M +9.69% | 382.0M +2.96% | 371.0M +2.77% | |
Total Short-Term Debt | 4.9B +4.07% | 4.7B +93.81% | 2.4B +555.14% | 370.0M +56.12% | |
Total Current Liabilities | 16.4B +7.73% | 15.2B +19.93% | 12.7B +27.80% | 9.9B +3.34% | |
Total Long-Term Debt | 41.6B +8.53% | 38.3B +3.13% | 37.2B -1.45% | 37.7B +9.82% | |
Total Long-Term Liabilities | 43.5B +8.11% | 40.2B +2.88% | 39.1B -1.00% | 39.5B +9.33% | |
Total Liabilities | 18.2B +6.83% | 17.0B +17.05% | 14.6B +24.92% | 11.7B +2.80% | |
Retained Earnings | -5.7B +170.64% | -2.1B +56.43% | -1.4B -40.70% | -2.3B +328.57% | |
Total Stockholders Equity | -6.0B +141.18% | -2.5B +40.87% | -1.8B -35.89% | -2.8B +196.57% | |
Total Shares Outstanding | 72,047 -99.97% | 250.0M -5.86% | 265.5M -4.27% | 277.4M -9.20% | |
Cash Flow | |||||
Cash from Operating Activities | 12.6B +20.18% | 10.5B +11.48% | 9.4B +10.67% | 8.5B -4.88% | |
Capital Expenditures | 4.9B +1.42% | 4.9B +2.76% | 4.7B +7.94% | 4.4B +22.87% | |
Cash from Investing Activities | -5.0B +1.11% | -4.9B -7.22% | -5.3B +56.89% | -3.4B +28.23% | |
Dividends Paid | 679.0M -1.59% | 690.0M +4.39% | 661.0M +1.23% | 653.0M +4.65% | |
Cash from Financing Activities | -8.6B +86.60% | -4.6B +11.92% | -4.1B -27.62% | -5.7B -15.01% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 13.01% +7.73% | 12.07% +1.77% | 11.86% -16.73% | 14.24% -14.89% | |
Return on Assets | 11.28% +13.36% | 9.95% +3.16% | 9.65% -11.78% | 10.94% -22.77% | |
Return on Equity | -159.14% -40.97% | -269.60% +16.77% | -230.87% -24.31% | -305.03% -92.08% | |
Revenue Growth | 7.08% -18.40% | 8.67% +10.33% | 7.86% +211.85% | 2.52% -82.01% | |
Current Ratio | 0.97 -10.74% | 1.08 -8.31% | 1.18 -14.39% | 1.38 -2.51% | |
Cash Ratio | 0.06 -50.08% | 0.13 +72.40% | 0.07 -19.41% | 0.09 -39.43% | |
Debt-to-Equity Ratio | -7.71 -55.20% | -17.22 -22.85% | -22.32 +62.16% | -13.76 -62.86% | |
Debt-to-Assets Ratio | 0.77 +5.89% | 0.72 +2.65% | 0.70 -3.02% | 0.73 +6.57% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow